current
cure
rabi
clinic
sign
appear
believ
rabv
enter
central
nervou
system
cn
viru
neutral
antibodi
vna
peripheri
pass
bloodbrain
barrier
bbb
cn
furthermor
hypothes
vna
produc
cn
invad
b
cell
rather
produc
peripheri
transport
cn
import
clear
rabv
cn
present
studi
mous
serum
contain
vna
administ
intraven
mice
infect
wildtyp
rabv
studi
demonstr
exogen
administr
vna
crucial
clearanc
rabv
brain
prevent
develop
rabi
immunocompet
immunocompromis
mice
long
bbb
permeabl
remain
enhanc
present
studi
therefor
provid
foundat
possibl
develop
vna
therapi
clinic
rabi
human
rabi
viru
rabv
negativesens
singlestrand
rna
viru
belong
lyssaviru
genu
rhabdovirida
famili
rupprecht
rhabdovirus
envelop
typic
bulletor
rodshap
morpholog
character
extrem
broad
host
spectrum
rang
plant
insect
mammal
rupprecht
rabi
known
deadli
neurolog
diseas
human
anim
centuri
jackson
remain
major
threat
public
health
jackson
knobel
et
al
martinez
meslin
et
al
year
rabi
caus
human
death
around
world
meslin
et
al
canin
rabi
respons
human
case
asia
africa
cleaveland
et
al
unit
state
dog
rabi
larg
brought
control
pet
vaccin
program
number
human
case
declin
dramat
past
year
hampson
et
al
human
case
usa
associ
rabv
found
bat
particularli
silverhair
bat
obviou
recogn
exposur
histori
messeng
et
al
morimoto
et
al
therefor
need
develop
therapeut
clinic
rabi
although
rabi
prevent
human
exposur
usual
anim
bite
postexposur
prophylaxi
pep
compris
wound
cleans
vaccin
administr
antirabi
immunoglobulin
pep
effect
initi
promptli
exposur
cdc
wide
accept
effect
treatment
rabi
infect
almost
alway
fatal
neurolog
symptom
develop
wild
although
human
survivor
report
recent
treatment
milwauke
protocol
modif
thereof
mcw
willoughbi
et
al
effect
question
hemachudha
et
al
jackson
mcdermid
et
al
rabi
clinic
sign
especi
neurolog
sign
believ
indic
viru
replic
result
neuron
dysfunct
injuri
central
nervou
system
cn
peripher
immun
effector
limit
access
yousaf
et
al
viral
infect
cn
pose
uniqu
challeng
immun
system
regard
control
elimin
invad
pathogen
griffin
presenc
bloodbrain
barrier
bbb
provid
physic
physiolog
separ
cn
peripheri
thu
cell
molecul
easili
enter
cn
ballabh
et
al
hosk
lane
roy
hooper
although
enhanc
bbb
permeabl
infiltr
inflammatori
cell
often
associ
patholog
chang
cn
infect
virus
hosk
lane
kim
et
al
phare
et
al
transient
increas
bbb
permeabl
found
help
clear
rabv
cn
induct
autoimmun
cn
inflamm
experiment
allerg
encephalomyel
administr
attenu
rabv
phare
et
al
well
recombin
rabv
express
three
copi
glycoprotein
g
triga
faber
et
al
immun
stimul
molecul
exampl
gmcsf
result
enhanc
bbb
permeabl
increas
product
viru
neutral
antibodi
vna
clearanc
rabv
cn
prevent
rabi
mous
model
furthermor
clearanc
attenu
rabv
cn
correl
infiltr
b
cell
cn
express
high
level
chain
mrna
phare
et
al
passivelytransf
vna
via
intraperiton
rout
insuffici
mediat
cn
clearanc
attenu
rabv
bcell
defici
mice
observ
led
hypothesi
vna
produc
situ
cn
invad
b
cell
rather
produc
peripheri
cross
cn
import
clear
rabv
cn
nevertheless
report
enhanc
bbb
permeabl
deliv
suffici
vna
brain
may
provid
effect
treatment
cn
infect
establish
liao
et
al
present
studi
intraven
administr
vna
found
crucial
clear
rabv
brain
prevent
anim
develop
rabi
immunocompet
bcell
defici
mice
long
bbb
permeabl
enhanc
street
rabv
dog
rabi
viru
mexico
drvmexico
dietzschold
et
al
zhang
fu
propag
suckl
mous
brain
mous
neuroblastoma
cell
na
maintain
rpmi
medium
mediatech
herndon
va
supplement
fetal
bovin
serum
fb
gibco
grand
island
ny
recombin
murin
monocyt
chemotact
protein
purchas
preprotech
rocki
hill
nj
rabvantibodi
posit
serum
prepar
blood
icr
mice
immun
rrabvgmcsf
vaccin
rabvneg
serum
prepar
blood
icr
mice
sera
pool
titrat
vna
four
sixweek
old
femal
icr
mice
purchas
harlan
indianapoli
four
sixweek
old
femal
j
b
cell
defici
purchas
jackson
laboratori
bar
harbor
mice
hous
temperatureand
lightcontrol
quarter
anim
resourc
facil
colleg
veterinari
medicin
univers
georgia
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
procedur
approv
institut
anim
care
use
committe
univers
georgia
anim
welfar
assur
number
effort
made
minim
anim
suffer
indic
time
point
whole
blood
collect
mice
allow
clot
overnight
spun
min
supernat
isol
serum
antibodi
analysi
mice
perfus
pb
rate
min
independ
sampl
mous
brain
group
homogen
prepar
wv
suspens
dmem
homogen
brain
sampl
centrifug
rpm
supernat
harvest
viru
titrat
antibodi
detect
western
blot
analysi
viru
titer
determin
direct
fluoresc
antibodi
assay
dfa
na
cell
na
cell
plate
inocul
serial
dilut
viru
prepar
incub
day
cultur
supernat
remov
cell
fix
icecold
aceton
min
cell
wash
twice
pb
stain
fitcconjug
antirabv
n
antibodi
fujirebio
malvern
pa
antigenposit
foci
count
fluoresc
microscop
zeiss
germani
viral
titer
calcul
fluoresc
focu
unit
ffu
per
millilit
titrat
carri
quadrupl
realtim
rt
sybr
green
pcr
assay
carri
apparatu
stratagen
la
jolla
ca
quantifi
express
viral
genom
rna
copi
number
well
mrna
tight
junction
protein
occludin
chain
total
rna
extract
brain
homogen
use
qiagen
rneasi
kit
qiagen
redwood
ca
treat
dnase
qiagen
revers
transcriptas
dna
polymeras
util
onestep
brilliant
ii
sybr
green
qrtpcr
master
mix
kit
stratagen
reaction
carri
duplic
approxim
ng
dnasetr
rna
nm
primer
pair
describ
previous
armstrong
et
al
branist
et
al
faber
et
al
phare
et
al
amplif
carri
min
min
follow
cycl
two
step
sec
min
absolut
quantif
viral
genom
rna
standard
curv
gener
use
serial
dilut
rna
vitro
transcrib
plasmid
express
rabv
g
copi
number
viral
genom
rna
normal
g
total
rna
measur
mrna
tight
junction
protein
chain
copi
number
normal
housekeep
gene
dehydrogenas
gapdh
level
gene
express
test
sampl
present
fold
increas
detect
shaminfect
control
vna
measur
carri
rffit
previous
describ
favoretto
et
al
serial
fivefold
dilut
serum
prepar
labtek
chamber
slide
nalg
nunc
intern
rochest
ny
fluoresc
foci
dose
fifti
ffd
challeng
viru
standard
ad
chamber
incub
min
na
cell
cell
ad
chamber
slide
incub
hr
cell
fix
icecold
aceton
stain
fitcconjug
antirabv
n
antibodi
hr
twenti
field
chamber
assess
fluoresc
microscop
endpoint
titer
calcul
accord
reedmeunch
formula
reed
muench
valu
compar
refer
serum
obtain
nation
institut
total
ig
g
elisa
assay
elisa
carri
use
mous
igg
titer
elisa
kit
gener
bioscienc
brisban
ca
accord
manufactur
instruct
optic
densiti
measur
nm
use
spectrophotomet
biotek
instrument
vt
determin
total
igg
concentr
perform
linear
regress
analysi
use
softwar
signatur
ver
biotek
instrument
standard
curv
prepar
use
known
concentr
mous
igg
provid
elisa
kit
gener
bioscienc
igg
concentr
sampl
control
calcul
correspond
refer
standard
curv
use
logist
regress
equat
program
result
express
brain
homogen
serum
sampl
bbb
permeabl
determin
measur
sodium
fluorescein
naf
uptak
previous
describ
kuang
et
al
phare
et
al
phare
et
al
mgml
naf
use
tracer
inject
tail
vein
mous
peripher
blood
collect
min
pbsperfus
brain
harvest
serum
recov
mix
equal
volum
trichloroacet
acid
tca
centrifug
min
supernat
collect
centrifug
made
mix
naoh
tca
homogen
brain
sampl
cold
tca
centrifug
min
x
g
remov
debri
supernat
made
ad
naoh
fluoresc
serum
brain
homogen
sampl
measur
use
spectrophotomet
biotek
instrument
excit
nm
emiss
nm
naf
taken
brain
tissu
express
microgram
fluoresc
per
mg
cerebrum
cerebellum
divid
microgram
fluoresc
per
serum
normal
uptak
amount
marker
peripher
blood
time
brain
tissu
collect
trout
et
al
data
express
fold
chang
amount
tracer
tissu
comparison
valu
obtain
tissu
neg
control
brain
homogen
subject
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
thermo
scientif
rockford
il
separ
protein
electroblot
onto
nitrocellulos
membran
incub
primari
antibodi
overnight
extens
wash
pb
blot
incub
secondari
antibodi
protein
detect
supersign
west
pico
chemiluminesc
thermo
scientif
band
signal
correspond
immunoreact
protein
captur
chemiluminesc
intens
analyz
use
ch
mp
documenta
system
biorad
ca
graphpad
prism
v
graphpad
softwar
inc
la
jolla
ca
usa
use
statist
analysi
surviv
curv
estim
kaplanmei
method
statist
signific
surviv
rate
experiment
group
determin
log
rank
test
student
ttest
oneway
anova
use
evalu
signific
differ
experiment
group
control
experiment
group
respect
statist
signific
set
p
previou
studi
reveal
intracerebr
administr
rrabvgmcsf
combin
inactiv
rrabv
prevent
mice
develop
rabi
stimul
product
vna
enhanc
bbb
permeabl
clear
rabv
cn
investig
intraven
administr
vna
togeth
protect
mice
rabv
infect
weekold
icr
mice
infect
intramuscularli
bicep
femori
muscl
left
hindlimb
mous
intramuscular
lethal
dose
street
rabv
drvmexico
describ
day
post
infect
dpi
mice
treat
intraven
tail
vein
rabvneg
serum
rabvantibodi
posit
serum
vna
titer
iu
enhanc
bbb
permeabl
mice
treat
intracerebr
recombin
murin
suspend
steril
ddh
known
transient
enhanc
bbb
permeabl
stamatov
et
al
mice
observ
daili
three
week
develop
rabi
result
shown
fig
infect
mice
treat
medium
die
day
pi
mice
surviv
treatment
combin
rabvneg
serum
posit
serum
alon
without
result
indic
treatment
alon
increas
surviv
rate
rabv
infect
absenc
passivelytransf
vna
without
vna
administ
intraven
unabl
pass
brain
clear
rabv
combin
treatment
rabvantibodi
posit
serum
increas
surviv
rate
p
brain
mice
surviv
three
week
treatment
succumb
time
death
rabi
harvest
viru
titrat
detect
antibodi
chain
rtpcr
phare
et
al
result
depict
fig
high
viru
titer
ffuml
detect
brain
mice
succumb
rabi
viru
detect
surviv
one
fig
similar
result
also
obtain
viral
genom
rna
detect
fig
high
vna
titer
detect
serum
surviv
mice
fig
chain
mrna
level
brain
significantli
higher
surviv
mice
dead
one
fig
result
indic
intraven
administr
vna
crucial
clearanc
rabv
brain
bbb
permeabl
enhanc
howev
detect
chain
brain
suggest
plasma
cell
enter
cn
could
produc
vna
situ
provid
protect
shown
singl
intracerebr
dose
ug
induc
fitcalbumin
leakag
mous
brain
stamatov
et
al
ensur
intraven
administ
rabv
vna
abl
reach
brain
bbb
permeabl
enhanc
icr
mice
given
rabvantibodi
posit
serum
intraven
without
antibodi
level
analyz
hr
later
brain
serum
result
depict
fig
level
vna
found
similar
serum
mice
without
treatment
fig
vna
level
brain
mice
treat
rabvantibodi
posit
serum
conjunct
significantli
higher
iu
mice
treat
vnaposit
serum
without
iu
fig
similar
find
also
observ
total
igg
level
measur
elisa
fig
result
demonstr
passiv
administ
vna
abl
pass
bbb
bbb
permeabl
enhanc
shown
enhanc
bbb
permeabl
hr
inject
effect
wane
hr
stamatov
et
al
investig
infect
wt
rabv
would
chang
dynam
bbb
permeabl
enhanc
mice
infect
drvmexico
treat
rabvantibodi
posit
neg
serum
dpi
naf
uptak
measur
mice
hr
treatment
shown
fig
infect
drvmexico
alon
chang
bbb
permeabl
compar
control
enhanc
bbb
permeabl
detect
hr
reach
peak
hr
declin
hr
inject
greater
effect
observ
cerebrum
cerebellum
fig
studi
indic
infect
rabv
chang
dynam
bbb
permeabl
enhanc
report
attract
leukocyt
increas
bbb
permeabl
redistribut
tight
junction
protein
reorgan
actin
cytoskeleton
stamatov
et
al
express
tight
junction
protein
occludin
measur
rtpcr
western
blot
describ
chai
et
al
invers
relationship
found
bbb
permeabl
express
tight
junction
protein
fig
naf
intak
increas
brain
mice
treatment
hr
express
tight
junction
protein
decreas
hr
bbb
permeabl
start
declin
hr
express
tight
junction
protein
increas
observ
confirm
quantit
western
blot
fig
result
suggest
enhanc
bbb
permeabl
possibl
downregul
tight
junction
protein
brain
vasculatur
determin
combin
treatment
rabvantibodi
posit
serum
crucial
clear
rabv
brain
mice
infect
drvmexico
dpi
mice
treat
without
rabvantibodi
posit
serum
anim
sacrif
hr
treatment
anim
also
sacrif
time
drvinfect
mice
without
treatment
develop
hindlimb
paralysi
reach
euthanasia
criteria
dpi
indic
surviv
dpi
indic
ensur
clearanc
rabv
brainin
establish
infect
brain
serum
sampl
collect
sacrif
mice
detect
vna
total
igg
viru
copi
number
mrna
level
chain
measur
brain
sampl
result
summar
fig
mice
treat
without
rabvantibodi
posit
serum
reach
euthanasia
criteria
therefor
sampl
collect
group
drv
mice
treat
without
rabvantibodi
posit
serum
detect
level
vna
found
brain
fig
serum
fig
observ
period
suggest
wt
rabv
drvmexico
incap
induc
vna
vna
detect
brain
shortli
hr
combin
treatment
rabvantibodi
posit
serum
level
vna
brain
reach
peak
hr
declin
fig
correspond
enhanc
bbb
permeabl
fig
serum
vna
level
remain
constant
administr
fig
vna
level
brain
serum
continu
signific
dpi
mice
treat
rabvantibodi
posit
serum
vna
remain
undetect
mice
treat
without
rabvantibodi
posit
serum
fig
mice
develop
sever
sign
rabi
hand
signific
differ
observ
igg
level
brain
serum
drvinfect
mice
treat
without
rabvantibodi
posit
serum
fig
igg
level
brain
peak
immedi
hr
administr
correl
time
bbb
permeabl
enhanc
fig
togeth
result
suggest
wt
rabv
fail
elicit
vna
respons
passivelytransf
rabvantibodi
posit
serum
along
need
mice
maintain
protect
vna
level
brain
shown
fig
viru
copi
number
increas
steadili
brain
mice
infect
drvmexico
treat
plu
rabvneg
serum
highest
viru
copi
number
observ
dpi
infect
mice
develop
sever
clinic
sign
contrast
viral
genom
rna
gradual
decreas
brain
mice
infect
drvmexico
treat
rabvantibodi
posit
serum
similar
result
also
observ
viru
titer
data
shown
decreas
viru
copi
number
titer
correspond
increas
vna
brain
dpi
viru
copi
number
brain
mice
treat
rabvneg
serum
time
mice
treat
rabvantibodi
posit
serum
similar
viru
copi
number
detect
brain
mice
infect
dvrmexico
treat
alon
without
treatment
dpi
day
treatment
viru
longer
detect
surviv
mice
treat
rabvantibodi
posit
serum
find
indic
alon
capabl
clear
rabv
brain
instead
intraven
administr
vna
addit
crucial
clear
rabv
brain
copi
number
klight
chain
detect
rtpcr
similar
brain
mice
treat
plu
rabvantibodi
posit
neg
serum
fig
level
low
begin
stage
infect
reach
high
level
dpi
howev
copi
number
chain
significantli
higher
mice
treatment
without
data
may
indic
plasma
cell
induc
infect
drvmexico
cross
bbb
treatment
exclud
possibl
vnaproduc
plasma
cell
enter
cn
absolut
requir
clear
rabv
cn
experi
summar
fig
repeat
bcell
defici
mice
j
bcell
defici
background
mice
inocul
intramuscularli
drvmexico
half
mice
left
untreat
half
treat
intraven
rabvantibodi
posit
serum
conjunct
dpi
without
treatment
vna
bcell
defici
mice
die
dpi
fig
eighti
percent
mice
treat
rabvantibodi
posit
serum
surviv
fig
chain
mrna
detect
cn
surviv
mice
fig
j
mice
surviv
treat
day
infect
fig
despit
fact
vna
titer
still
high
serum
fig
might
due
fact
vna
level
declin
hr
inject
fig
thu
addit
dose
given
day
infect
increas
significantli
p
surviv
rate
given
dpi
given
dpi
j
mice
fig
yet
chain
detect
cn
mice
fig
viru
detect
brain
mice
succumb
rabi
surviv
fig
result
clear
antibodyproduc
plasma
cell
absolut
requir
clear
rabv
suffici
vna
allow
enter
cn
previou
studi
indic
intracerebr
administr
rrabvgmcsf
could
stimul
product
vna
enhanc
bbb
permeabl
clear
rabv
brain
therefor
prevent
mice
develop
rabi
late
day
infect
wt
rabv
howev
administr
inactiv
rrabvgmcsf
improv
surviv
rate
despit
fact
vna
produc
peripheri
yet
enhanc
bbb
permeabl
could
improv
survivor
rate
mice
treat
inactiv
rrabvgmcsf
present
studi
demonstr
exogen
deliv
vna
crucial
clear
establish
infect
wt
rabv
brain
prevent
develop
rabi
immunocompet
immunodefici
mice
long
bbb
permeabl
remain
enhanc
despit
natur
infect
mice
rare
mous
model
use
mani
rabi
studi
given
short
incub
period
unlik
human
rabv
may
take
week
reach
cn
site
exposur
caus
clinic
ill
spread
rabv
cn
mice
rapid
viru
gener
detect
cn
tissu
within
hour
infect
hooper
clinic
sign
particularli
neurolog
sign
believ
indic
neuron
injurydysfunct
relat
viru
replic
cn
neuron
hindlimb
paralysi
major
neurolog
sign
rabi
infect
mice
may
best
endpoint
wt
rabi
infect
mice
especi
given
infect
spinal
neuron
believ
caus
hindlimb
paralysi
infect
laboratori
rabi
strain
howev
previou
studi
demonstr
highest
rabv
titer
detect
brain
dpi
right
rabvinfect
mice
develop
hindlimb
paralysi
therefor
use
human
endpoint
present
studi
demonstr
clearanc
rabv
cn
passiv
transfer
antibodi
also
minim
suffer
infect
mice
bbb
physic
physiolog
barrier
form
endotheli
tight
junction
imped
influx
compound
peripher
circul
enter
cn
abbott
et
al
ballabh
et
al
thu
bbb
play
import
role
maintain
homeostasi
cn
neuwelt
enhanc
bbb
permeabl
often
associ
cn
diseas
spindler
hsu
virus
lymphocyt
choriomening
viru
attenu
rabv
infect
cn
enhanc
bbb
permeabl
result
infiltr
inflammatori
cell
patholog
chang
kim
et
al
phare
et
al
wt
rabv
infect
howev
bbb
permeabl
enhanc
sinc
rabv
bypass
bbb
enter
cn
via
axon
transport
directli
site
peripher
inocul
roy
hooper
enhanc
bbb
permeabl
thu
requir
immun
effector
enter
cn
clear
rabv
prevent
occurr
rabi
phare
et
al
enhanc
bbb
permeabl
rabv
clearanc
cn
labattenu
rabv
phare
et
al
recombin
rabv
express
three
copi
g
faber
et
al
gmcsf
wen
et
al
directli
inject
brain
found
stimul
vna
product
enhanc
bbb
permeabl
result
clearanc
rabv
cn
prevent
develop
rabi
mous
model
infect
wt
rabv
report
transient
enhanc
bbb
permeabl
mice
without
caus
obviou
side
effect
stamatov
et
al
use
enhanc
bbb
permeabl
rabv
clearanc
previou
studi
present
studi
role
enhanc
bbb
permeabl
investig
includ
dynam
bbb
permeabl
chang
level
rabv
vna
brain
downregul
tight
junction
protein
brain
vasculatur
singl
intracerebr
dose
enhanc
bbb
permeabl
significantli
control
mice
enhanc
reach
peak
hr
observ
similar
previous
report
stamatov
et
al
administr
result
reduct
tj
protein
occludin
express
studi
known
enhanc
bbb
permeabl
correl
reduct
tj
protein
express
brain
vasculatur
chai
et
al
kirk
et
al
kniesel
wolburg
liao
et
al
result
support
function
role
cytoplasm
anchorag
tj
particl
brain
endotheli
barrier
function
vna
level
brain
also
measur
evalu
whether
compromis
bbb
allow
antibodi
leak
brain
possibl
interfer
circul
antibodi
particularli
vna
brain
vasculatur
minim
pb
perfus
sampl
collect
previous
describ
yu
et
al
alway
possibl
residu
antibodi
pass
bbb
may
complet
elimin
perfus
howev
vna
brain
found
significantli
higher
mice
treat
combin
vna
mice
treat
vna
alon
indic
significantli
vna
pass
bbb
treatment
sinc
vna
level
serum
similar
anim
therefor
enhanc
bbb
permeabl
allow
intraven
administ
vna
pass
bbb
brain
inhibit
rabv
replic
lead
eventu
clearanc
rabv
brain
prevent
develop
rabi
without
intraven
administ
vna
pass
bbb
clear
rabv
brain
prevent
develop
rabi
enhanc
bbb
permeabl
alon
howev
prevent
develop
rabi
mice
infect
wt
rabv
demonstr
clearli
previou
studi
although
capabl
recruit
leukocyt
cn
yadav
et
al
intracerebr
inject
may
induc
local
inflamm
secondari
mechan
stimuli
ic
alon
combin
ic
neg
serum
iv
insuffici
clear
wt
rabv
brain
prevent
develop
rabi
studi
indic
alon
mechan
stimuli
intracerebr
inject
lead
clearanc
rabv
brain
increas
surviv
vna
suggest
produc
brain
mice
infect
attenu
rabv
may
thu
contribut
rabv
clearanc
howev
known
long
time
natur
infect
wt
rabv
induc
strong
antivir
immun
respons
baltazard
ghodssi
hemachuda
et
al
report
less
human
rabi
patient
develop
vna
time
death
present
studi
vna
detect
mice
infect
drvmexico
mice
die
without
intervent
find
suggest
although
nonvna
could
made
brain
contribut
surviv
wt
rabi
infect
mechan
wt
rabv
induc
product
vna
entir
clear
moment
studi
warrant
hypothes
vna
produc
situ
cn
invad
b
cell
produc
peripheri
transport
cn
import
clear
rabv
cn
passiv
transfer
vna
via
intraperiton
rout
fail
clear
attenu
rabv
brain
bcell
defici
mice
howev
studi
summar
demonstr
differ
result
wt
rabvinfect
mous
model
like
relev
clinic
rabi
human
intraven
administ
vna
import
clear
wt
rabv
brain
prevent
develop
rabi
immunocompet
mice
also
bcell
defici
mice
long
bbb
permeabl
remain
enhanc
thu
product
vna
situ
brain
plasma
cell
absolut
requir
wt
rabv
clearanc
brain
similar
result
also
report
coronavirusinduc
encephalomyel
although
recruit
virusspecif
antibodysecret
cell
asc
mediat
found
help
control
coronavirusinduc
encephalomyel
marqu
et
al
phare
et
al
viral
recrudesc
prevent
bcelldefici
ig
mice
intraperiton
administr
jhmvspecif
neutral
antibodi
lin
et
al
ramakrishna
et
al
thu
find
demonstr
product
vna
situ
brain
antibodysecret
cell
asc
absolut
requir
clearanc
virus
brain
found
studi
administ
twice
dpi
bcell
defici
mice
order
achiev
similar
rate
protect
found
immunocompet
mice
one
inject
attribut
transient
natur
enhanc
bbb
permeabl
stamatov
et
al
low
level
vna
present
brain
iu
despit
fact
vna
level
serum
remain
high
thu
continu
enhanc
bbb
permeabl
requir
maintain
suffici
vna
level
brain
clear
rabv
specul
b
cell
defici
mice
could
mediat
nonantibodi
depend
antivir
mechan
thu
play
role
clearanc
rabv
brain
howev
mice
die
without
treat
rabv
antibodyposit
serum
mice
surviv
treat
twice
treat
indic
vna
pass
brain
peripheri
play
decis
role
clear
rabv
brain
bcell
defici
mice
although
tradit
inactiv
rabv
vaccin
use
preand
postexposur
prophylaxi
human
high
safeti
efficaci
use
delay
treatment
even
acceler
rabi
cdc
rupprecht
et
al
sampath
et
al
vaccin
liveattenu
rabv
vaccin
recombin
vaccin
express
rabv
g
limit
use
wildlif
anim
brochier
et
al
hanlon
et
al
schumach
et
al
recent
studi
suggest
liveattenu
vaccin
express
multipl
copi
g
immunestimul
molecul
potenti
replac
tradit
inactiv
rabv
vaccin
also
clear
rabv
cn
administ
intracerebr
faber
et
al
wang
et
al
howev
intracerebr
administr
liveattenu
recombin
rabv
still
possess
safeti
concern
result
demonstr
vna
administ
intraven
rout
crucial
rabv
clearanc
brain
appear
clinic
sign
would
interest
initi
treatment
appear
clinic
sign
howev
still
obstacl
overcom
exampl
viru
burden
increas
chang
neuron
injurydysfunct
may
revers
late
stage
rabv
infect
thu
studi
warrant
nevertheless
find
present
studi
provid
foundat
develop
vna
therapi
human
clinic
rabi
intraven
administr
vna
protect
mice
develop
rabi
bbb
permeabl
enhanc
enhanc
bbb
permeabl
downregul
tj
protein
brain
microvasculatur
enhanc
bbb
permeabl
correl
increas
vna
clearanc
rabv
cn
